AI Article Synopsis
- Guidelines for Lu-PSMA-617 therapy are important but often lack practical details for comprehensive institutional protocols.
- A survey was conducted to evaluate the crucial components of the Lu-PSMA-617 protocol across various stages of therapy.
- The findings reveal significant variability in how institutions determine eligibility and administer Lu-PSMA-617, which might benefit both new and established theranostic programs.
Article Abstract
Although guidelines for the use of Lu-PSMA-617 published by various organizations are important, they do not include all the essential, practical points necessary for a complete institutional protocol. Therefore, a brief survey was performed to assess key components of the Lu-PSMA-617 protocol before, during, and after delivery of therapy. This survey demonstrated the wide variability in many aspects of institutional protocols regarding determination of eligibility for and administration of Lu-PSMA-617 therapy. The real-world protocol details provided here from a variety of institutions may help new and established theranostic programs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2967/jnmt.123.266769 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!